Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Bevacizumab Neoadjuvant Therapy for New High-grade Gliomas in the Brain

NCT06747728 is registered in ClinicalTrials.gov with The First Affiliated Hospital of Zhengzhou University as lead sponsor.

NCT NCT06747728
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06747728 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Bevacizumab Neoadjuvant Therapy for New High-grade Gliomas in the Brain
Lead sponsor
The First Affiliated Hospital of Zhengzhou University
Phase
Not applicable
Overall status
Recruiting
Start date
March 1, 2024
Completion date
June 1, 2026
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

brain glioma